ACLF Market Innovations: Seal Rock–GENFIT Collaboration Expands Novel Liver Disease Therapies
The global Acute On Chronic Liver Failure (ACLF) Market was valued at US$ 3.2 billion in 2023 and is projected to reach US$ 5.8 billion by 2031, with a compound annual growth rate (CAGR) of 7.2% during the forecast period 2024-2031, according to DataM Intelligence. Acute-on-Chronic Liver Failure (ACLF) is a severe syndrome involving rapid liver function deterioration in patients with chronic...
0 Comentários 0 Compartilhamentos 446 Visualizações 0 Anterior
Patrocinado
Patrocinado
Patrocinado
Patrocinado